Literature DB >> 7318359

Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man.

J A Millar, K McLean, J L Reid.   

Abstract

1. The effect of the calcium antagonist nifedipine on the pressor and aldosterone responses to angiotensin II was studied in six normal subjects. 2. Blood pressure, pulse rate and plasma aldosterone, potassium and cortisol were measured during paired consecutive infusions of angiotensin II (5, 10 and 20 ng min-1 kg-1) on two separate occasions. Nifedipine (20 mg by mouth) was given, 30 min before the second set of infusions. 3. After nifedipine there were reciprocal changes in supine resting blood pressure (-7 mmHg) and pulse rate (+18 min-1) and a significant decrease in the pressor response to angiotensin II (P less than 0.05; Wilcoxon signed rank test). 4. Basal levels of aldosterone were not changed by nifedipine, but the response to angiotensin II was significantly attenuated (P less than 0.05). Nifedipine had no effect on plasma potassium or cortisol. 5. Transmembrane movement of calcium is involved in the aldosterone response to angiotensin II in man. Calcium antagonists may lower blood pressure via decreased adrenal responsiveness to angiotensin II as well as by peripheral vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318359     DOI: 10.1042/cs061065s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects.

Authors:  K Handa; T Mori; H Tanaka; Y Takada; A Matsunaga; A Kiyonaga; M Shindo; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

2.  Influence of nicardipine on blood pressure, renal function and plasma aldosterone in normotensive volunteers.

Authors:  B A van Schaik; R J Hene; G G Geyskes
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

3.  The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

4.  The influence of alpha 1-adrenergic blockade on the acute antihypertensive effect of nifedipine.

Authors:  H E Sluiter; F T Huysmans; T A Thien; R A Koene
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Nitrendipine and the humoral control of sodium homeostasis.

Authors:  D R Forsyth; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

7.  Effect of verapamil on aldosterone secretion in primary aldosteronism.

Authors:  G Opocher; S Rocco; A Murgia; F Mantero
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

8.  Effects of nicardipine on aldosterone release and pressor mechanisms.

Authors:  H L Elliott; F Pasanisi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

9.  Nifedipine in the treatment of hypertension: report of a double-blind controlled trial.

Authors:  S Bayley; R J Dobbs; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.